Raidium Overview
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.17M
- Investors
-
16
Raidium General Information
Description
Developer of a radiology-augmented technology designed to tackle the complexity of precision medicine. The company utilizes deep learning algorithms for the analysis of medical imaging data and develops a radiology console that brings artificial intelligence assistance directly to the radiologist's workflow via a diagnosis suggestion interface, enabling customers' access to imaging with a focus on screening, allowing earlier management of potential lethal diseases such as cancer, cardiovascular or metabolic pathologies.
Contact Information
Website
www.raidium.euCorporate Office
- 29 Rue Du Faubourg Saint-Jacques
- 75014 Paris
- France
Corporate Office
- 29 Rue Du Faubourg Saint-Jacques
- 75014 Paris
- France
Raidium Timeline
Raidium Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Seed Round | 24-Sep-2025 | $1.17M | Completed | Generating Revenue | ||
| 12. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 11-Dec-2024 | Completed | Generating Revenue | |||
| 9. Seed Round | 27-Nov-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 13-Nov-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 24-Oct-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 19-Sep-2024 | Completed | Generating Revenue | |||
| 5. Grant | 14-Mar-2024 | $2.71M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Raidium Patents
Raidium Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026093678-A1 | Device and method for training a segmentation model, and method and device for segmenting a three-dimensional object | Pending | 29-Oct-2024 | ||
| FR-3168060-A1 | Device and method for training a segmentation model, method and device for segmenting a three-dimensional object. | Pending | 29-Oct-2024 | ||
| FR-3159699-A1 | Device and method for annotating medical images | Active | 28-Feb-2024 | ||
| FR-3159699-B1 | Device and method for annotating medical images | Active | 28-Feb-2024 | G06V10/761 |
Raidium Signals
Raidium Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| La French Tech | Accelerator/Incubator | |||
| StartX (US) | Accelerator/Incubator | |||
| ByTheTower | Venture Capital | Minority | ||
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| Founders Future | Venture Capital | Minority |
Raidium FAQs
-
Where is Raidium headquartered?
Raidium is headquartered in Paris, France.
-
What is the size of Raidium?
Raidium has 39 total employees.
-
What industry is Raidium in?
Raidium’s primary industry is Other Healthcare Technology Systems.
-
Is Raidium a private or public company?
Raidium is a Private company.
-
What is Raidium’s current revenue?
The current revenue for Raidium is .
-
How much funding has Raidium raised over time?
Raidium has raised $18.2M.
-
Who are Raidium’s investors?
La French Tech, StartX (US), ByTheTower, Debiopharm Innovation Fund, and Founders Future are 5 of 16 investors who have invested in Raidium.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process